Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

NCT05188911 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05188911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05188911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2020
Completion date
July 15, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, metastatic disease, prostate cancer